Noah Labs

Noah Labs develops Ark, a Class IIa medical device software platform for remote patient monitoring. The platform integrates external cardiac devices and implants with Noah Labs Vox, a proprietary AI algorithm designed to detect early signs of cardiac decompensation in outpatient settings.

The company serves hospitals, cardiology practices, and cardiac clinics across Germany and Europe. Customers use Ark to enable remote monitoring, faster clinical interventions, and reduced hospitalizations. The company conducts clinical trials in partnership with major medical institutions including University Medical Center Maastricht and Clinic Barcelona.

Noah Labs was founded in 2021 by Oliver Piepenstock (CEO), Marcus Hott (CTO, machine learning expert), and Dr. Leonhard Riehle (CMedO, cardiologist), who met through the Entrepreneur First incubator program. The company is headquartered in Berlin with additional sales presence in Cologne. Support includes partnerships with the German Heart Center Foundation, EIT Health, Google for Startups, Creative Destruction Lab, and the ProFIT Brandenburg government grant program. Current hiring includes senior AI product engineers, clinical trial managers, and regional sales managers.

Product: Ark - Class IIa medical device telemonitoring software integrated with Noah Labs Vox AI algorithm for cardiac decompensation detection